Vinblastine, adriamycin, thiotepa, and halotestin (VATH). Therapy for advanced breast cancer refractory to prior chemotherapy (Q39638726)

reason for preferred rank

13 September 2017

title

Vinblastine, adriamycin, thiotepa, and halotestin (VATH). Therapy for advanced breast cancer refractory to prior chemotherapy (English)

1 reference

10.1002/1097-0142(197812)42:6<2534::AID-CNCR2820420605>3.0.CO;2-P

https://api.crossref.org/works/10.1002/1097-0142(197812)42:6%3C2534::AID-CNCR2820420605%3E3.0.CO;2-P

24 November 2022

Vinblastine, adriamycin, thiotepa, and halotestin (VATH): therapy for advanced breast cancer refractory to prior chemotherapy (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A103610

24 November 2022

1 reference

1 reference

1 reference

10.1002/1097-0142(197812)42:6<2534::AID-CNCR2820420605>3.0.CO;2-P

https://api.crossref.org/works/10.1002/1097-0142(197812)42:6%3C2534::AID-CNCR2820420605%3E3.0.CO;2-P

24 November 2022

author name string

M. Perloff

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A103610

24 November 2022

R. D. Hart

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A103610

24 November 2022

J. F. Holland

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A103610

24 November 2022

language of work or name

English

0 references

publication date

1 December 1978

1 reference

full work available at URL

13 September 2017

number of pages

4

1 reference

based on heuristic

inferred from page(s)

https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1002%2F1097-0142(197812)42:6%3C2534::AID-CNCR2820420605%3E3.0.CO;2-P

1 reference

10.1002/1097-0142(197812)42:6<2534::AID-CNCR2820420605>3.0.CO;2-P

https://api.crossref.org/works/10.1002/1097-0142(197812)42:6%3C2534::AID-CNCR2820420605%3E3.0.CO;2-P

https://onlinelibrary.wiley.com/doi/full/10.1002/1097-0142(197812)42:6%3C2534::AID-CNCR2820420605%3E3.0.CO;2-P

24 November 2022

1 reference

10.1002/1097-0142(197812)42:6<2534::AID-CNCR2820420605>3.0.CO;2-P

https://api.crossref.org/works/10.1002/1097-0142(197812)42:6%3C2534::AID-CNCR2820420605%3E3.0.CO;2-P

24 November 2022

1 reference

13 September 2017

volume

42

1 reference

13 September 2017

issue

6

1 reference

13 September 2017

page(s)

2534-2537

1 reference

Design and analysis of randomized clinical trials requiring prolonged observation of each patient. II. analysis and examples

13 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1002%2F1097-0142%28197812%2942%3A6%3C2534%3A%3AAID-CNCR2820420605%3E3.0.CO%3B2-P

Response and survival in advanced breast cancer after two non-cross-resistant combinations

21 January 2018

1

1 reference

10.1002/1097-0142(197812)42:6<2534::AID-CNCR2820420605>3.0.CO;2-P

https://api.crossref.org/works/10.1002/1097-0142(197812)42:6%3C2534::AID-CNCR2820420605%3E3.0.CO;2-P

An effective low-dose intermittent cyclophosphamide, methotrexate, and 5-fluorouracil treatment regimen for metastatic breast cancer

24 November 2022

3

1 reference

10.1002/1097-0142(197812)42:6<2534::AID-CNCR2820420605>3.0.CO;2-P

https://api.crossref.org/works/10.1002/1097-0142(197812)42:6%3C2534::AID-CNCR2820420605%3E3.0.CO;2-P

Assessment of response to therapy in advanced breast cancer: a project of the Programme on Clinical Oncology of the International Union Against Cancer, Geneva, Switzerland

24 November 2022

4

1 reference

10.1002/1097-0142(197812)42:6<2534::AID-CNCR2820420605>3.0.CO;2-P

https://api.crossref.org/works/10.1002/1097-0142(197812)42:6%3C2534::AID-CNCR2820420605%3E3.0.CO;2-P

1,-(2-chloroethyl)-3-cyclohexyl-1-nitrosourea (methyl CCNU) and adriamycin combination therapy

24 November 2022

5

1 reference

10.1002/1097-0142(197812)42:6<2534::AID-CNCR2820420605>3.0.CO;2-P

https://api.crossref.org/works/10.1002/1097-0142(197812)42:6%3C2534::AID-CNCR2820420605%3E3.0.CO;2-P

24 November 2022

Cancer Treatment Reports

6

60

1687

Muss

1976

1 reference

10.1002/1097-0142(197812)42:6<2534::AID-CNCR2820420605>3.0.CO;2-P

https://api.crossref.org/works/10.1002/1097-0142(197812)42:6%3C2534::AID-CNCR2820420605%3E3.0.CO;2-P

Adriamycin, 1,3-bis (2-chloroethyl)-1-nitrosourea (BCNU, NSC 409962) and cyclophosphamide therapy of drug-resistant metastatic breast carcinoma

24 November 2022

8

1 reference

10.1002/1097-0142(197812)42:6<2534::AID-CNCR2820420605>3.0.CO;2-P

https://api.crossref.org/works/10.1002/1097-0142(197812)42:6%3C2534::AID-CNCR2820420605%3E3.0.CO;2-P

24 November 2022

10

37

529

Tormey

1977

1 reference

10.1002/1097-0142(197812)42:6<2534::AID-CNCR2820420605>3.0.CO;2-P

https://api.crossref.org/works/10.1002/1097-0142(197812)42:6%3C2534::AID-CNCR2820420605%3E3.0.CO;2-P

24 November 2022

Identifiers

10.1002/1097-0142(197812)42:6<2534::AID-CNCR2820420605>3.0.CO;2-P

1 reference

13 September 2017

1 reference